Details for New Drug Application (NDA): 061449
✉ Email this page to a colleague
NDA 061449 describes STAPHCILLIN, which is a drug marketed by Apothecon and is included in two NDAs. Additional details are available on the STAPHCILLIN profile page.
The generic ingredient in STAPHCILLIN is methicillin sodium. There are three drug master file entries for this compound. Additional details are available on the methicillin sodium profile page.
The generic ingredient in STAPHCILLIN is methicillin sodium. There are three drug master file entries for this compound. Additional details are available on the methicillin sodium profile page.
Summary for 061449
| Tradename: | STAPHCILLIN |
| Applicant: | Apothecon |
| Ingredient: | methicillin sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 061449
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 900MG BASE/VIAL | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 3.6GM BASE/VIAL | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 5.4GM BASE/VIAL | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
